PWA
GMAB icon

Physician Wealth Advisors’s Genmab GMAB Stock Holding History

Physician Wealth Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.71K Sell
135
-30
-18% -$797 ﹤0.01% 1229
2026
Q1 		$4.43K Hold
165
– – ﹤0.01% 1048
2025
Q4 		$5.08K Hold
165
– – ﹤0.01% 969
2025
Q3 		$5.06K Buy
165
+70
+74% +$1.71K ﹤0.01% 924
2025
Q2 		$1.96K Buy
+95
New +$1.95K ﹤0.01% 1050
2025
Q1 		– Sell
-160
Closed -$3.34K – 1477
2024
Q4 		$3.34K Buy
+160
New +$3.52K ﹤0.01% 789

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Physician Wealth Advisors's GMAB Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Genmab (GMAB) stake by 18% in Q2 2026, selling an estimated $797 and leaving 135 shares worth $3.71K. The position accounts for ﹤0.01% of the portfolio, ranked #1229.

Physician Wealth Advisors first reported a position in GMAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.08K in Q4 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Physician Wealth Advisors held 135 shares of Genmab worth $3.71K as of Q2 2026.
  • Physician Wealth Advisors sold 30 Genmab shares in Q2 2026, an estimated $797.
  • Genmab made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1229 holding.
  • Physician Wealth Advisors first reported a position in Genmab in Q4 2024 and has held it in 6 quarters since.
  • Physician Wealth Advisors's Genmab position peaked at $5.08K in Q4 2025.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.